Current Perspectives on the Role of Matrix Metalloproteinases in the Pathogenesis of Basal Cell Carcinoma

Basal cell carcinoma (BCC) is the most common skin malignancy, which rarely metastasizes but has a great ability to infiltrate and invade the surrounding tissues. One of the molecular players involved in the metastatic process are matrix metalloproteinases (MMPs). MMPs are enzymes that can degrade v...

Full description

Saved in:
Bibliographic Details
Published in:Biomolecules (Basel, Switzerland) Switzerland), 2021-06, Vol.11 (6), p.903
Main Authors: Tampa, Mircea, Georgescu, Simona Roxana, Mitran, Madalina Irina, Mitran, Cristina Iulia, Matei, Clara, Caruntu, Ana, Scheau, Cristian, Nicolae, Ilinca, Matei, Andreea, Caruntu, Constantin, Constantin, Carolina, Neagu, Monica
Format: Article
Language:English
Subjects:
Angiogenesis
Basal cell carcinoma
BCC
Carcinogenesis
Cell adhesion & migration
Enzymes
Extracellular matrix
Growth factors
Heparan sulfate
invasion
Kinases
Malignancy
Matrix metalloproteinase
Metastases
Metastasis
MMP
Pathogenesis
Proteins
Review
Sarcoma
Skin cancer
TIMP
Tumor microenvironment
tumor progression
Ultraviolet radiation
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Basal cell carcinoma (BCC) is the most common skin malignancy, which rarely metastasizes but has a great ability to infiltrate and invade the surrounding tissues. One of the molecular players involved in the metastatic process are matrix metalloproteinases (MMPs). MMPs are enzymes that can degrade various components of the extracellular matrix. In the skin, the expression of MMPs is increased in response to various stimuli, including ultraviolet (UV) radiation, one of the main factors involved in the development of BCC. By modulating various processes that are linked to tumor growth, such as invasion and angiogenesis, MMPs have been associated with UV-related carcinogenesis. The sources of MMPs are multiple, as they can be released by both neoplastic and tumor microenvironment cells. Inhibiting the action of MMPs could be a useful therapeutic option in BCC management. In this review that reunites the latest advances in this domain, we discuss the role of MMPs in the pathogenesis and evolution of BCC, as molecules involved in tumor aggressiveness and risk of recurrence, in order to offer a fresh and updated perspective on this field.
ISSN:2218-273X
2218-273X
DOI:10.3390/biom11060903